References
- 1
Weetman AP.
The genetics of autoimmune thyroid disease.
Horm Metab Res.
2009;
41
421-425
- 2
Dultz G, Matheis N, Dittmar M, Bender K, Kahaly GJ.
CTLA-4 CT60 polymorphism in thyroid and polyglandular autoimmunity.
Horm Metab Res.
2009;
41
426-429
- 3
Glowacka D, Loesch C, Johnson KTM, Mann K, Esser J, Morgenthaler NG, Siffert W, Schmid KW,
Eckstein AK.
The T393C polymorphism of the Gαs gene (GNAS1) is associated with the course of Graves’
disease.
Horm Metab Res.
2009;
41
430-435
- 4
Tanda ML, Piantanida E, Lai A, Lombardi V, Dalle Mule I, Liparulo L, Pariani N, Bartalena L.
Thyroid autoimmunity and environment.
Horm Metab Res.
2009;
41
436-442
- 5
Duntas LH.
Selenium and inflammation: underlying anti-inflammatory mechanisms.
Horm Metab Res.
2009;
41
443-447
- 6
Rees Smith B, Sanders J, Evans M, Tagami T, Furmaniak J.
TSH receptor – autoantibody interactions.
Horm Metab Res.
2009;
41
448-455
- 7
Sanders J, Chirgadze DY, Sanders P, Baker S, Sullivan A, Bhardwaja A, Bolton J, Reeve M,
Nakatake N, Evans M, Richards T, Powell M, Núñez Miguel R, Blundell TL, Furmaniak J,
Rees Smith B.
Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody.
Thyroid.
2007;
17
395-410
- 8
Sheu SY, Grabellus F, Schwertheim S, Handke S, Worm K, Schmid KW.
Lack of correlation between BRAF V600E mutational status and the expression profile
of a distinct set of miRNAs in papillary thyroid carcinoma.
Horm Metab Res.
2009;
41
482-487
- 9
Schwertheim S, Sheu SY, Worm K, Grabellus F, Schmid KW.
Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid
carcinoma from papillary thyroid carcinoma.
Horm Metab Res.
2009;
41
475-481
- 10
Zhu XG, Cheng SY.
Modeling thyroid cancer in the mouse.
Horm Metab Res.
2009;
41
488-499
- 11
Suzuki H, Willingham MC, Cheng SY.
Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop
thyroid carcinoma: a mouse model of thyroid carcinogenesis.
Thyroid.
2002;
12
963-969
- 12
Ying H, Suzuki H, Zhao L, Willingham MC, Meltzer P, Cheng SY.
Mutant thyroid hormone receptor beta represses the expression and transcriptional
activity of peroxisome proliferator-activated receptor gamma during thyroid carcinogenesis.
Cancer Res.
2003;
63
5274-5280
- 13
Spitzweg C.
Gene therapy in thyroid cancer.
Horm Metab Res.
2009;
41
500-509
Correspondence
Dr. M. SchottMD, PhD
Department of Endocrinology
Diabetes and Rheumatology
University Hospital Düsseldorf
Moorenstraße 5
40225 Düsseldorf
Germany
Phone: +49/211/81 17 810
Fax: +49/211/81 17 860
Email: matthias.schott@med.uni-duesseldorf.de
